Annual Operating Profit
$158.10 M
+$112.14 M+243.96%
31 December 2023
Summary:
BioMarin Pharmaceutical annual operaing income is currently $158.10 million, with the most recent change of +$112.14 million (+243.96%) on 31 December 2023. During the last 3 years, it has risen by +$249.93 million (+272.16%). BMRN annual operating profit is now at all-time high.BMRN Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$113.89 M
-$6.56 M-5.45%
30 September 2024
Summary:
BioMarin Pharmaceutical quarterly operating income is currently $113.89 million, with the most recent change of -$6.56 million (-5.45%) on 30 September 2024. Over the past year, it has increased by +$88.32 million (+345.42%). BMRN quarterly operating profit is now -5.45% below its all-time high of $120.45 million, reached on 30 June 2024.BMRN Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$327.09 M
+$88.32 M+36.99%
30 September 2024
Summary:
BioMarin Pharmaceutical TTM operating income is currently $327.09 million, with the most recent change of +$88.32 million (+36.99%) on 30 September 2024. Over the past year, it has increased by +$197.45 million (+152.31%). BMRN TTM operating profit is now at all-time high.BMRN TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +244.0% | +345.4% | +152.3% |
| 3 y3 years | +272.2% | +321.7% | +730.4% |
| 5 y5 years | +202.0% | +2740.2% | +309.8% |
BMRN Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +272.2% | -5.5% | +277.3% | at high | +540.0% |
| 5 y | 5 years | at high | +202.0% | -5.5% | +277.3% | at high | +309.8% |
| alltime | all time | at high | +156.2% | -5.5% | +227.1% | at high | +210.3% |
BioMarin Pharmaceutical Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $113.89 M(-5.4%) | $327.09 M(+37.0%) |
| June 2024 | - | $120.45 M(+53.5%) | $238.76 M(+29.8%) |
| Mar 2024 | - | $78.46 M(+449.5%) | $183.88 M(+9.6%) |
| Dec 2023 | $158.10 M(+244.0%) | $14.28 M(-44.2%) | $167.82 M(+29.5%) |
| Sept 2023 | - | $25.57 M(-61.0%) | $129.64 M(+26.4%) |
| June 2023 | - | $65.57 M(+5.1%) | $102.59 M(+33.1%) |
| Mar 2023 | - | $62.40 M(-361.1%) | $77.08 M(+67.6%) |
| Dec 2022 | $45.96 M(-161.8%) | -$23.90 M(+1522.7%) | $46.00 M(+710.8%) |
| Sept 2022 | - | -$1.47 M(-103.7%) | $5.67 M(-112.8%) |
| June 2022 | - | $40.05 M(+27.9%) | -$44.22 M(-37.2%) |
| Mar 2022 | - | $31.33 M(-148.8%) | -$70.44 M(-5.2%) |
| Dec 2021 | -$74.33 M(-19.1%) | -$64.23 M(+25.1%) | -$74.33 M(+43.3%) |
| Sept 2021 | - | -$51.36 M(-471.6%) | -$51.89 M(-4.9%) |
| June 2021 | - | $13.82 M(-49.6%) | -$54.59 M(-50.1%) |
| Mar 2021 | - | $27.44 M(-165.7%) | -$109.34 M(+19.7%) |
| Dec 2020 | -$91.83 M(-12.4%) | -$41.79 M(-22.7%) | -$91.37 M(+89.9%) |
| Sept 2020 | - | -$54.06 M(+32.1%) | -$48.11 M(-583.1%) |
| June 2020 | - | -$40.93 M(-190.1%) | $9.96 M(-284.2%) |
| Mar 2020 | - | $45.41 M(+2989.3%) | -$5.41 M(-94.8%) |
| Dec 2019 | -$104.83 M(-32.4%) | $1.47 M(-63.3%) | -$104.77 M(-32.8%) |
| Sept 2019 | - | $4.01 M(-107.1%) | -$155.90 M(-11.2%) |
| June 2019 | - | -$56.30 M(+4.4%) | -$175.65 M(+6.7%) |
| Mar 2019 | - | -$53.95 M(+8.6%) | -$164.62 M(+6.2%) |
| Dec 2018 | -$155.04 M(+11.0%) | -$49.66 M(+215.5%) | -$155.04 M(-10.0%) |
| Sept 2018 | - | -$15.74 M(-65.2%) | -$172.33 M(+1.2%) |
| June 2018 | - | -$45.26 M(+2.0%) | -$170.31 M(+3.9%) |
| Mar 2018 | - | -$44.37 M(-33.7%) | -$163.86 M(+17.3%) |
| Dec 2017 | -$139.70 M(-31.6%) | -$66.95 M(+387.7%) | -$139.70 M(-14.0%) |
| Sept 2017 | - | -$13.73 M(-64.6%) | -$162.37 M(-22.2%) |
| June 2017 | - | -$38.81 M(+92.1%) | -$208.73 M(+45.4%) |
| Mar 2017 | - | -$20.21 M(-77.5%) | -$143.60 M(-29.7%) |
| Dec 2016 | -$204.31 M(-27.4%) | -$89.62 M(+49.2%) | -$204.31 M(+10.9%) |
| Sept 2016 | - | -$60.09 M(-328.4%) | -$184.17 M(-10.6%) |
| June 2016 | - | $26.31 M(-132.5%) | -$205.96 M(-30.6%) |
| Mar 2016 | - | -$80.92 M(+16.5%) | -$296.56 M(+5.3%) |
| Dec 2015 | -$281.50 M(+75.5%) | -$69.48 M(-15.1%) | -$281.50 M(+4.0%) |
| Sept 2015 | - | -$81.87 M(+27.4%) | -$270.78 M(+10.4%) |
| June 2015 | - | -$64.29 M(-2.4%) | -$245.20 M(+22.7%) |
| Mar 2015 | - | -$65.86 M(+12.1%) | -$199.79 M(+24.6%) |
| Dec 2014 | -$160.39 M(+3.4%) | -$58.76 M(+4.4%) | -$160.39 M(+4.8%) |
| Sept 2014 | - | -$56.30 M(+198.2%) | -$153.01 M(+3.8%) |
| June 2014 | - | -$18.88 M(-28.6%) | -$147.43 M(-0.8%) |
| Mar 2014 | - | -$26.46 M(-48.5%) | -$148.60 M(-4.2%) |
| Dec 2013 | -$155.07 M(+40.7%) | -$51.37 M(+1.3%) | -$155.07 M(+3.0%) |
| Sept 2013 | - | -$50.72 M(+153.0%) | -$150.60 M(+36.5%) |
| June 2013 | - | -$20.05 M(-39.1%) | -$110.37 M(-9.0%) |
| Mar 2013 | - | -$32.92 M(-29.8%) | -$121.27 M(+10.0%) |
| Dec 2012 | -$110.22 M(+225.2%) | -$46.90 M(+347.1%) | -$110.22 M(+30.1%) |
| Sept 2012 | - | -$10.49 M(-66.1%) | -$84.75 M(-5.6%) |
| June 2012 | - | -$30.95 M(+41.6%) | -$89.77 M(+46.3%) |
| Mar 2012 | - | -$21.87 M(+2.0%) | -$61.37 M(+66.3%) |
| Dec 2011 | -$33.89 M | -$21.43 M(+38.1%) | -$36.90 M(+47.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | -$15.52 M(+507.1%) | -$25.02 M(+234.8%) |
| June 2011 | - | -$2.56 M(-198.1%) | -$7.47 M(+2441.8%) |
| Mar 2011 | - | $2.61 M(-127.3%) | -$294.00 K(+167.3%) |
| Dec 2010 | $544.00 K(-96.7%) | -$9.56 M(-570.0%) | -$110.00 K(-100.7%) |
| Sept 2010 | - | $2.03 M(-56.0%) | $15.83 M(-33.9%) |
| June 2010 | - | $4.62 M(+65.7%) | $23.93 M(+1.3%) |
| Mar 2010 | - | $2.79 M(-56.3%) | $23.62 M(+43.8%) |
| Dec 2009 | $16.43 M(-58.7%) | $6.38 M(-37.0%) | $16.43 M(-61.0%) |
| Sept 2009 | - | $10.13 M(+134.9%) | $42.10 M(+22.7%) |
| June 2009 | - | $4.31 M(-198.0%) | $34.32 M(-0.6%) |
| Mar 2009 | - | -$4.40 M(-113.7%) | $34.54 M(-13.1%) |
| Dec 2008 | $39.76 M(-169.4%) | $32.06 M(+1263.5%) | $39.76 M(-1872.4%) |
| Sept 2008 | - | $2.35 M(-48.1%) | -$2.24 M(-89.8%) |
| June 2008 | - | $4.53 M(+453.8%) | -$21.90 M(-45.3%) |
| Mar 2008 | - | $818.00 K(-108.2%) | -$40.03 M(-30.5%) |
| Dec 2007 | -$57.29 M(+132.2%) | -$9.94 M(-42.6%) | -$57.64 M(-2.7%) |
| Sept 2007 | - | -$17.31 M(+27.3%) | -$59.26 M(+28.6%) |
| June 2007 | - | -$13.60 M(-19.0%) | -$46.07 M(+36.3%) |
| Mar 2007 | - | -$16.79 M(+45.2%) | -$33.80 M(+37.0%) |
| Dec 2006 | -$24.67 M(-61.6%) | -$11.56 M(+180.9%) | -$24.67 M(-4.9%) |
| Sept 2006 | - | -$4.12 M(+207.9%) | -$25.94 M(-25.9%) |
| June 2006 | - | -$1.34 M(-82.5%) | -$34.99 M(-33.3%) |
| Mar 2006 | - | -$7.66 M(-40.3%) | -$52.43 M(-18.3%) |
| Dec 2005 | -$64.21 M(-56.6%) | -$12.83 M(-2.6%) | -$64.21 M(-52.4%) |
| Sept 2005 | - | -$13.17 M(-29.8%) | -$134.94 M(-9.1%) |
| June 2005 | - | -$18.77 M(-3.4%) | -$148.39 M(+0.3%) |
| Mar 2005 | - | -$19.44 M(-76.7%) | -$148.02 M(+0.1%) |
| Dec 2004 | -$147.91 M(+95.1%) | -$83.56 M(+213.9%) | -$147.91 M(+65.3%) |
| Sept 2004 | - | -$26.62 M(+44.7%) | -$89.47 M(+7.1%) |
| June 2004 | - | -$18.40 M(-4.8%) | -$83.52 M(+12.0%) |
| Mar 2004 | - | -$19.34 M(-23.0%) | -$74.59 M(-1.6%) |
| Dec 2003 | -$75.80 M(+12.1%) | -$25.11 M(+21.5%) | -$75.80 M(-1.5%) |
| Sept 2003 | - | -$20.67 M(+118.1%) | -$76.94 M(+7.9%) |
| June 2003 | - | -$9.48 M(-53.9%) | -$71.32 M(-4.7%) |
| Mar 2003 | - | -$20.54 M(-21.7%) | -$74.81 M(+10.6%) |
| Dec 2002 | -$67.62 M(+42.0%) | -$26.25 M(+74.5%) | -$67.62 M(+13.4%) |
| Sept 2002 | - | -$15.05 M(+16.0%) | -$59.61 M(+9.9%) |
| June 2002 | - | -$12.97 M(-2.8%) | -$54.24 M(+5.7%) |
| Mar 2002 | - | -$13.35 M(-26.8%) | -$51.29 M(+10.6%) |
| Dec 2001 | -$47.63 M(+33.5%) | -$18.24 M(+88.5%) | -$46.38 M(+13.6%) |
| Sept 2001 | - | -$9.67 M(-3.6%) | -$40.84 M(+3.6%) |
| June 2001 | - | -$10.03 M(+18.8%) | -$39.42 M(+7.8%) |
| Mar 2001 | - | -$8.44 M(-33.5%) | -$36.57 M(+2.5%) |
| Dec 2000 | -$35.67 M(+38.3%) | -$12.70 M(+54.0%) | -$35.67 M(+17.4%) |
| Sept 2000 | - | -$8.25 M(+14.7%) | -$30.38 M(+1.5%) |
| June 2000 | - | -$7.19 M(-4.7%) | -$29.93 M(+3.8%) |
| Mar 2000 | - | -$7.54 M(+1.9%) | -$28.84 M(+11.4%) |
| Dec 1999 | -$25.80 M(+100.0%) | -$7.40 M(-5.2%) | -$25.88 M(+40.0%) |
| Sept 1999 | - | -$7.80 M(+27.9%) | -$18.48 M(+73.0%) |
| June 1999 | - | -$6.10 M(+33.1%) | -$10.68 M(+133.1%) |
| Mar 1999 | - | -$4.58 M | -$4.58 M |
| Dec 1998 | -$12.90 M | - | - |
FAQ
- What is BioMarin Pharmaceutical annual operaing income?
- What is the all time high annual operating profit for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual operating profit year-on-year change?
- What is BioMarin Pharmaceutical quarterly operating income?
- What is the all time high quarterly operating profit for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly operating profit year-on-year change?
- What is BioMarin Pharmaceutical TTM operating income?
- What is the all time high TTM operating profit for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM operating profit year-on-year change?
What is BioMarin Pharmaceutical annual operaing income?
The current annual operating profit of BMRN is $158.10 M
What is the all time high annual operating profit for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual operaing income is $158.10 M
What is BioMarin Pharmaceutical annual operating profit year-on-year change?
Over the past year, BMRN annual operaing income has changed by +$112.14 M (+243.96%)
What is BioMarin Pharmaceutical quarterly operating income?
The current quarterly operating profit of BMRN is $113.89 M
What is the all time high quarterly operating profit for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly operating income is $120.45 M
What is BioMarin Pharmaceutical quarterly operating profit year-on-year change?
Over the past year, BMRN quarterly operating income has changed by +$88.32 M (+345.42%)
What is BioMarin Pharmaceutical TTM operating income?
The current TTM operating profit of BMRN is $327.09 M
What is the all time high TTM operating profit for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM operating income is $327.09 M
What is BioMarin Pharmaceutical TTM operating profit year-on-year change?
Over the past year, BMRN TTM operating income has changed by +$197.45 M (+152.31%)